pillbase.ru

Симулект®

Active substance: basiliximab

лиофилизат для приготовления раствора для внутривенного введения, 20 мг, 20 мг (original in Russian, GRLS)

RussiaActive

Marketing holder: Новартис Фарма АГ

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Simulect
    INJECTION, POWDER, FOR SOLUTION · BASILIXIMAB 20 mg/5mL
    0078-0331
    Novartis Pharmaceuticals Corporation
  • Simulect
    INJECTION, POWDER, FOR SOLUTION · BASILIXIMAB 10 mg/2.5mL
    0078-0393
    Novartis Pharmaceuticals Corporation
  • basiliximab
    INJECTION, POWDER, FOR SOLUTION · BASILIXIMAB 10 mg/2.5mL
    17088-0370
    Novartis Pharma Stein AG
EU 1
  • Simulect
    basiliximab
    EMEA/H/C/000207
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-c00a-7c73-9bec-57ebaddb184c,01a120c5-4c73-743c-9ad8-5b66f6bc919f,01a120c6-7613-78e1-bf9d-ce294e7ea4f7;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12093-3c1f-71a0-b4e8-80f45b6c0e2d,01a12093-3f11-72f4-b8d2-664f8ff52f12,01a12097-e6f6-7b5b-ad79-35bacbc65ea4;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-№(011247)-(РГ-RU)
Registration status
Active
Dispensing
Prescription only
Release forms
лиофилизат для приготовления раствора для внутривенного введения, 20 мг, 20 мг - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-№(011247)-(РГ-RU) · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-№(011247)-(РГ-RU) · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-№(011247)-(РГ-RU) · Verified 2026-10-09